Sorrento Therapeutics
EXECUTIVE Q&A
FOUNDED: 1989
CEO: Henry Ji
HEADQUARTERS: Sorrento Valley
BUSINESS: Clinical stage, antibody-centric, biopharmaceutical company developing new therapies to treat cancers and COVID-19
REVENUE: $39.99 million (2020 Total Revenue)
STOCK: SRNE...
Read latest San Diego Business Journal online.
Online newspapers
at PressDisplay.